Literature DB >> 23777204

Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo.

Mitesh Dwivedi1, Naresh C Laddha, Kriti Shah, Bela J Shah, Rasheedunnisa Begum.   

Abstract

Interferon-gamma (IFN-γ) is a paracrine inhibitor of melanocytes and genetic variability due to intron 1 polymorphisms in IFNG has been reported to be associated with increased risk for several autoimmune diseases. The aim of present study was to determine whether intron 1 +874A/T (rs2430561) and CA microsatellite (rs3138557) polymorphisms in IFNG are associated with generalized vitiligo (GV) susceptibility and expression of IFNG and intercellular adhesion molecule-1 (ICAM1) affects the disease onset and progression. Here we report that IFNG CA microsatellite but not +874A/T may be a genetic risk factor for GV; however, +874T allele plays a crucial role in increased expression of IFNG mRNA and protein levels which could affect the onset and progression of the disease. Active GV patients showed increased IFNG levels compared to stable GV patients. The genotype-phenotype analysis revealed that IFNG expression levels were higher in patients with +874 TT genotypes and 12 CA repeats. Patients with the early age of onset showed higher IFNG expression and female GV patients showed higher IFNG and ICAM1 expression implicating gender biasness and involvement of IFN-γ in early onset of the disease. Moreover, the increased IFN-γ levels in patients lead to increased ICAM1 expression, which could be a probable link between cytokines and T-cell involvement in pathogenesis of GV.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23777204      PMCID: PMC3814581          DOI: 10.1089/jir.2012.0171

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  88 in total

1.  A differential association of interferon-gamma high-producing allele T and low-producing allele A (+874 A/T) with Hashimoto's thyroiditis and Graves' disease.

Authors:  P L Rekha; M Ishaq; V Valluri
Journal:  Scand J Immunol       Date:  2006-10       Impact factor: 3.487

2.  The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force.

Authors:  Alain Taïeb; Mauro Picardo
Journal:  Pigment Cell Res       Date:  2007-02

3.  Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) in isolated vitiligo: a genotype-phenotype correlation.

Authors:  Mitesh Dwivedi; Naresh C Laddha; Mohomad Imran; Bela J Shah; Rasheedunnisa Begum
Journal:  Pigment Cell Melanoma Res       Date:  2011-08       Impact factor: 4.693

4.  Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset.

Authors:  Ying Jin; Stanca A Birlea; Pamela R Fain; Katherine Gowan; Sheri L Riccardi; Paulene J Holland; Dorothy C Bennett; Deborah M Herbstman; Margaret R Wallace; Wayne T McCormack; E Helen Kemp; David J Gawkrodger; Anthony P Weetman; Mauro Picardo; Giovanni Leone; Alain Taïeb; Thomas Jouary; Khaled Ezzedine; Nanny van Geel; Jo Lambert; Andreas Overbeck; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2011-02-17       Impact factor: 8.551

5.  New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions.

Authors:  Silvia Moretti; Adelina Spallanzani; Lauretta Amato; Giuseppe Hautmann; Isabella Gallerani; Massimo Fabiani; Paolo Fabbri
Journal:  Pigment Cell Res       Date:  2002-04

Review 6.  Immunomodulation as a treatment strategy for genital herpes: review of the evidence.

Authors:  R L Miller; M A Tomai; C J Harrison; D I Bernstein
Journal:  Int Immunopharmacol       Date:  2002-03       Impact factor: 4.932

7.  Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells.

Authors:  J Cui; J C Bystryn
Journal:  Arch Dermatol       Date:  1995-03

Review 8.  Cytokines in autoimmune disorders.

Authors:  M Feldmann; F M Brennan; R Maini
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

9.  Th17 cells and activated dendritic cells are increased in vitiligo lesions.

Authors:  Claire Q F Wang; Andres E Cruz-Inigo; Judilyn Fuentes-Duculan; Dariush Moussai; Nicholas Gulati; Mary Sullivan-Whalen; Patricia Gilleaudeau; Jules A Cohen; James G Krueger
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

10.  Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.

Authors:  Naresh C Laddha; Mitesh Dwivedi; Rasheedunnisa Begum
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more
  13 in total

Review 1.  The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour.

Authors:  A Farzi; F Reichmann; P Holzer
Journal:  Acta Physiol (Oxf)       Date:  2015-01-09       Impact factor: 6.311

Review 2.  The Role of the NKG2D in Vitiligo.

Authors:  Lourdes Plaza-Rojas; José A Guevara-Patiño
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

Review 3.  Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo.

Authors:  K C Webb; R Tung; L S Winterfield; A B Gottlieb; J M Eby; S W Henning; I C Le Poole
Journal:  Br J Dermatol       Date:  2015-08-25       Impact factor: 9.302

4.  Tumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibility.

Authors:  Naresh C Laddha; Mitesh Dwivedi; Amina R Gani; Mohmmad Shoab Mansuri; Rasheedunnisa Begum
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

5.  A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat.

Authors:  Shahnawaz D Jadeja; Mohmmad Shoab Mansuri; Mala Singh; Mitesh Dwivedi; Naresh C Laddha; Rasheedunnisa Begum
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

Review 6.  The Role of MicroRNAs in Vitiligo: Regulators and Therapeutic Targets.

Authors:  Lili Li
Journal:  Ann Dermatol       Date:  2020-11-11       Impact factor: 1.444

7.  Association of IFN-γ : IL-10 Cytokine Ratio with Nonsegmental Vitiligo Pathogenesis.

Authors:  Yaswanth Ala; Mohammed Khalid Pasha; Raja Narasimha Rao; Prasanna Latha Komaravalli; Parveen Jahan
Journal:  Autoimmune Dis       Date:  2015-09-09

8.  Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility.

Authors:  Naresh C Laddha; Mitesh Dwivedi; Mohmmad Shoab Mansuri; Mala Singh; Hetanshi H Patel; Nishtha Agarwal; Anish M Shah; Rasheedunnisa Begum
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

9.  Association of genetic polymorphisms in interferon-γ, interleukin-6 and transforming growth factor-β1 gene with oral lichen planus susceptibility.

Authors:  Maha Ali M Al-Mohaya; Lubna Al-Otaibi; Fahad Al-Harthi; Ebtissam Al Bakr; Misbahul Arfin; Abdulrahman Al-Asmari
Journal:  BMC Oral Health       Date:  2016-08-20       Impact factor: 2.757

Review 10.  A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis.

Authors:  Shahnawaz D Jadeja; Jay M Mayatra; Jayvadan Vaishnav; Nirali Shukla; Rasheedunnisa Begum
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.